Long-Time Horizon Analysis of Hims & Hers Health Inc (HIMS) Stock

A share price of Hims & Hers Health Inc [HIMS] is currently trading at $9.87, up 0.20%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 11.27% over the last week, with a monthly amount glided 14.37%, and seem to be holding up well over a long-time horizon.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

On 5, February 2024, Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024. In a post published today on Yahoo Finance, Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

From an analyst’s perspective:

Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on December 07, 2023, when Imperial Capital initiated its In-line rating and assigned the stock a price target of $9.

Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $5.65 and $12.34. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $9.87 at the most recent close of the market.

Analyzing the HIMS fundamentals

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.76 points at the first support level, and at 9.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.03, and for the 2nd resistance point, it is at 10.18.

Hims & Hers Health Inc [HIMS] reported earnings per share of -$0.04 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.03/share, meaning a difference of -$0.01 and a surprise factor of -33.30%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.03 per share as compared to estimates of -$0.05 per share, a difference of $0.02 representing a surprise of 40.00%.

Ratios To Look Out For

A current ratio of 3.03 is a noteworthy aspect of Hims & Hers Health Inc [NYSE:HIMS].

Transactions by insiders

Recent insider trading involved Dudum Andrew, Chief Executive Officer, that happened on Jan 29 when 15100.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Jan 26 to sell 52940.0 shares. Meanwhile, Chief Executive Officer Dudum Andrew sold 0.13 million shares on Jan 25.

Related Posts